Colitis, ulcerative Trials in Belgrade, Serbia
Conditions / Colitis, ulcerative / Belgrade, Serbia
Research into Colitis, ulcerative spans multiple therapeutic approaches and trial phases.
15 total trials for this combination
Showing top 10 of 15 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT00487539 | An Efficacy and Safety Study of Golimumab (CNTO 148) in Participants With Moderately to Severely Active Ulcerative Colitis | COMPLETED | PHASE2/PHASE3 |
| NCT02620046 | A Study of Long-term Effects of Vedolizumab Subcutaneous in Adults With Ulcerative Colitis and Crohn's Disease | COMPLETED | PHASE3 |
| NCT07012395 | A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis | RECRUITING | — |
| NCT02497469 | An Efficacy and Safety Study of Vedolizumab Intravenous (IV) Compared to Adalimumab Subcutaneous (SC) in Participants With Ulcerative Colitis | COMPLETED | PHASE3 |
| NCT07012395 | A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis | RECRUITING | — |
| NCT00488774 | An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis | TERMINATED | PHASE2/PHASE3 |
| NCT07012395 | A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis | RECRUITING | — |
| NCT02407236 | A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis | COMPLETED | PHASE3 |
| NCT00488631 | An Efficacy and Safety Study of Golimumab (CNTO 148) in Participants With Moderately to Severely Active Ulcerative Colitis | COMPLETED | PHASE3 |
| NCT07012395 | A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis | RECRUITING | — |